Sixty-four patients with prostatic cancer were treated by various methods including total prostatectomy, castration, administration of hormone agents, estramustine phosphate disodium (EMP), anticancer chemotherapy agents by VIP-regimen and radiation at The 2nd Tokyo National Hospital, Tokyo, from 1980 to April 1985.
Early efficacy rates at 12 weeks were as follows; in CR+MR of estrogen therapy group, they were 760 (stages A, B, and C), and 590 (stage D). For groups of no change and progressive deterioration, it was 16% (stage D). Of EMP group, CR+MR cases were 86% (stages A, B, and C), and 43% (stage D), dead cases were 430 (stage D). Of VIP-regimen group MR cases were 670 (stage D), dead cases were 330 (stage D). Radiation therapy was responsible for local pain.
Actual survival rates (Kaplan-Meier) at 1, 3 and 5 years in untreated group (n=58) were 93%, 73%, and 72%, respectively. In refractory group (n=6) they were 90%, 41%, and 30%, respectively. They were 97%, 83%, and 82% for stages A, B, and C, respectively. They were 84%, 43%, and 0% for stage D. In G-1 group they were 95%, 78%, and 74%. And in G-3 group they were 86%, 37% and 36%.
View full abstract